Combinations of a PI3K/AKT inhibitor compound with an HER3/EGFR inhibitor compound and use thereof in the treatment of a hyperproliferative disorder

• 收藏
• 分享

专利权人:

THE GENERAL HOSPITAL CORPORATION

发明人:

Jose Baselga,Maurizio Scaltriti

申请号：

US14649889

公开号：

US09566334B2

申请日:

2013.12.09

申请国别(地区):

US

年份:

2017

代理人:

摘要：

The invention provides combinations comprising GDC-0068 or GDC-0941, or a pharmaceutically acceptable salt thereof and ME-HD7945A. The combinations are particularly useful for treating hyperproliferative disorders, such as cancer (e.g., triple negative breast cancer).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/